The facility has 40,000 square feet of manufacturing space for nitinol sheet and tubing, double the capacity of the company’s previous location in San Jose, California. The newly constructed plant in Mexicali is the world’s only low-cost-country manufacturer of nitinol sheet and tube, Johnson Matthey said in a news release.
The site is scheduled to be fully operational by 2023.
Johnson Matthey said the new facility will give its customers increased capacity for device launches, optimized cost, enhanced quality assurance and dependable deliveries with shorter leadtimes. Additionally, Mexicali’s proximity to Jonson Matthey’s San Diego facility will allow for consistency with JM’s company values, business processes and management oversight, the company said.
“With 35 years of nitinol experience, this is a new and exciting chapter,” Johnson Matthey Medical Device Components Managing Director Donald Freeman said in the news release. “Our team works hard to establish honest, collaborative partnerships with our customers to help them reach their goals. With our new facility we will be able to optimize costs and deliver high-quality products. Every customer will benefit from our focus on quality, on-time delivery, capacity management and competitive pricing.”